Delayed-Onset Hypnopompic Visual Hallucinations 20 Years After Initiation of Propranolol Therapy for Systemic Hypertension: A Case Report.
Denise T M Au Eong, Ryan L J Chiew, Kah-Guan Au Eong
The American journal of case reports July 25, 2024 DOI: 10.12659/ajcr.944342 (opens in new tab) via PubMed
Summary
AI-generated from the abstractAn 88-year-old woman began experiencing visual hallucinations 20 years after starting propranolol for hypertension, with symptoms persisting for 20 years. Hallucinations included plants, insects, and vivid human figures of various types, occurring daily upon awakening and lasting 10-20 seconds. After switching to atenolol, hallucinations became rare and non-frightening, indicating a drug-induced cause. This case highlights that iatrogenic causes should be considered even when hallucinations appear decades after starting a medication.
Study at a glance
| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | An 88-year-old woman with hypertension |
| Key finding | Visual hallucinations that began 20 years after starting propranolol resolved dramatically after switching to atenolol, suggesting a drug-induced etiology. |
Abstract
BACKGROUND Visual hallucinations occur in a variety of clinical settings and may be extremely troubling to individuals experiencing them. We report a case of delayed-onset visual hallucinations 20 years after initiation of medical therapy to highlight the importance of considering iatrogenic causes when managing such patients. CASE REPORT An 88-year-old woman presented with recurring hypnopompic formed visual hallucinations for the past 20 years. These hallucinations began 20 years after she was started on propranolol to treat her systemic hypertension 40 years earlier. Her hallucinations began with plants and insects. They later progressed to vivid, detailed human figures of different races, ages, genders, and religious personnel such as monks, nuns, and priests. The hallucinations occurred almost daily and upon awakening from sleep. Each episode of visual hallucinations lasted for 10 to 20 seconds, occurring when she awoke after dozing off, multiple times each day. The patient became mentally distressed by her visual hallucinations and began to attribute them to supernatural causes. After substituting her propranolol with atenolol, the patient's hallucinations decreased dramatically and became rare and non-frightening. The dramatic improvement suggested a drug-induced etiology. CONCLUSIONS Our case illustrates the importance of considering iatrogenic causes in the diagnosis of visual hallucinations and having a high index of suspicion, even if the onset of symptoms is delayed for many years after initiation of therapy. This iatrogenic condition can easily be rectified to drastically improve the quality of life in affected patients.